Clinical Trial for the Optimization of Indocyanine Green Administration in NIRF-C During L.Cholecystectomy.

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

May 16, 2023

Study Completion Date

October 24, 2023

Conditions
Laparoscopic Cholecystectomy
Interventions
DRUG

VERDYE powder for solution for injection 25 mg

Verdye 25 mg contains sodium VI powder for solution for injection. VI is a water-soluble agent with a spectral absorption peak of 800 nm. It is a drug approved for diagnostic use only and is indicated for the measurement of the excretory function of the liver.

Trial Locations (2)

37007

Complejo Asistencial Universitario de Salamanca, Salamanca

08916

Hospital Universitario Germans Trias i Pujol., Badalona

All Listed Sponsors
collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

lead

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

OTHER